Device Trial Radar · NCT04628221
Open Label Study Using OsteoProbe System
Last checked: Nov 20, 2026Latest source record: Apr 27, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jul 31, 2020
Primary completion
Nov 30, 2020
Study completion Dec 30, 2020
Sponsor
- Lead sponsor
- Active Life Scientific, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- MCRA
- First posted
- Nov 13, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Prospective, Single Center, Open Label Clinical Study. The purpose of the study is to collect safety data associated with the use of the OsteoProbe System. Study Duration is expected to take approximately 3 months from first subject enrolled to the last follow-up visit.
Conditions
- Adverse Effects in the Use of the OsteoProbe System
Interventions
OsteoProbe SystemDevice
The OsteoProbe® System ("OsteoProbe") is a bone microindentation measurement tool. The device is a measurement tool that is not intended to make a diagnosis or provide a treatment decision. There are no other available measurement tools for clinical assessment of bone's resistance to microindentation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Number of Participants With Reported Device Related Serious Adverse Events.Time frame: Procedure
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Meridian Clinical Research, LLC.
Omaha, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.